Mumbai-based Wockhardt is recalling 1,62,142 cartons of various drugs, which are used to treat ailments like high blood pressure and ulcer, in the US market due to deviations in current good manufacturing practice (cGMP) norms laid down by the American health regulator. As per the information available on the US Food and Drug Administration's (USFDA) website, Wockhardt is recalling the drugs for cGMP deviations. "Firm did not adequately investigate customer complaints," the USFDA said.
展开▼
